Amylyx Pharmaceuticals, Inc. — Investor Relations & Filings
Amylyx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of novel therapies for neurodegenerative diseases and other conditions with high unmet medical needs. The company's primary therapeutic candidate was AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS). In April 2024, following the results of a Phase 3 clinical trial, Amylyx announced it would voluntarily withdraw the marketing authorizations for AMX0035 in the U.S. and Canada. The company is advancing a pipeline of other investigational therapies, utilizing a modality-agnostic approach to match treatments to diseases based on mechanistic rationale and rigorous scientific data.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-05-07 | English | |
| 8-K - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-05-07 | English | |
| ARS - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-04-23 | English | |
| DEF 14A - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-04-23 | English | |
| 8-K - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-03-24 | English | |
| 4 - AMYLYX PHARMACEUTICALS, INC. (0001658551) (Filer) | 2026-03-04 | English |
Browse filings by year
12 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Dermata Therapeutics, Inc.
Medical dermatology company developing and commercializing …
|
DRMA | US | Manufacturing |
|
Desh Rakshak Aushdhalaya Ltd.
Manufacturer of GMP-certified Ayurvedic and herbal medicine…
|
531521 | IN | Manufacturing |
|
Design Therapeutics, Inc.
Clinical-stage biopharma developing small molecule therapie…
|
DSGN | US | Manufacturing |
|
Deutsche Biotech Innovativ AG
Develops therapeutics for serious diseases using innovative…
|
DBI | DE | Manufacturing |
|
DEVA HOLDİNG A.Ş.
Develops, produces, and markets human medicines, APIs, and …
|
DEVA | ES | Manufacturing |
|
Devonian Health Group Inc
Clinical-stage botanical pharmaceutical company focused on …
|
GSD | CA | Manufacturing |
|
Devyser Diagnostics
Develops DNA testing kits for hereditary diseases, oncology…
|
DVYSR | SE | Manufacturing |
|
DexTech Medical AB
Develops drug candidates for urological oncology, focusing …
|
DEX | SE | Manufacturing |
|
Dezhan Healthcare Company Limited
Researches and produces cardiovascular chemical drugs and o…
|
000813 | CN | Manufacturing |
|
DiaMedica Therapeutics Inc.
Clinical-stage biopharma developing therapies for ischemic …
|
DMAC | US | Manufacturing |
Amylyx Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31865/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31865 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31865 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31865 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31865}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Amylyx Pharmaceuticals, Inc. (id: 31865)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.